[article]
| Titre : |
Practical Paediatric Psychopharmacological Prescribing in Autism: The Potential and the Pitfalls |
| Type de document : |
Texte imprimé et/ou numérique |
| Auteurs : |
Paul GRINGRAS, Auteur |
| Article en page(s) : |
p.229-247 |
| Langues : |
Anglais (eng) |
| Index. décimale : |
PER Périodiques |
| Résumé : |
Claims of ‘miracle cures’ for autism in the press and on the Internet bring new pressures to bear on parents of children with autism, and the professionals who care for them. Between a third and a half of people with autism in America are receiving some psychotropic medication. Despite recent advances in paediatric psychopharmacology, there is no proof that any medication can target the primary social impairments that characterize autism. The article discusses the evidence behind two approaches to psychopharmacological management in children with autism. The first approach selects certain target symptoms such as resistance to change, ritualistic/compulsive behaviours, hyperactivity, aggressive behaviours and sleep problems. The evidence for the effectiveness of agents including stimulants, anti- depressants, and melatonin when used to treat these symptoms is appraised. The second approach attempts to treat or cure the primary social impairment underlying autism. The evidence for the effectiveness of agents including naltrexone, fenfluramine and secretin is appraised. Early reports in this field have generated false hope, and the need for well-designed larger multicentre trials is emphasized. |
| En ligne : |
http://dx.doi.org/10.1177/1362361300004003002 |
| Permalink : |
https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=208 |
in Autism > 4-3 (September 2000) . - p.229-247
[article] Practical Paediatric Psychopharmacological Prescribing in Autism: The Potential and the Pitfalls [Texte imprimé et/ou numérique] / Paul GRINGRAS, Auteur . - p.229-247. Langues : Anglais ( eng) in Autism > 4-3 (September 2000) . - p.229-247
| Index. décimale : |
PER Périodiques |
| Résumé : |
Claims of ‘miracle cures’ for autism in the press and on the Internet bring new pressures to bear on parents of children with autism, and the professionals who care for them. Between a third and a half of people with autism in America are receiving some psychotropic medication. Despite recent advances in paediatric psychopharmacology, there is no proof that any medication can target the primary social impairments that characterize autism. The article discusses the evidence behind two approaches to psychopharmacological management in children with autism. The first approach selects certain target symptoms such as resistance to change, ritualistic/compulsive behaviours, hyperactivity, aggressive behaviours and sleep problems. The evidence for the effectiveness of agents including stimulants, anti- depressants, and melatonin when used to treat these symptoms is appraised. The second approach attempts to treat or cure the primary social impairment underlying autism. The evidence for the effectiveness of agents including naltrexone, fenfluramine and secretin is appraised. Early reports in this field have generated false hope, and the need for well-designed larger multicentre trials is emphasized. |
| En ligne : |
http://dx.doi.org/10.1177/1362361300004003002 |
| Permalink : |
https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=208 |
|
Practical Paediatric Psychopharmacological Prescribing in Autism: The Potential and the Pitfalls in Autism, 4-3 (September 2000)
